REFG OTC
Medical Cannabis Payment Solutions
1W: -99.7%
1M: -99.7%
3M: -99.7%
YTD: -99.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±24512.8%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$22K
+0.0% ▲
Operating Income
-$34K
+98.1% ▲
Net Income
-$34K
+97.9% ▲
EPS (Diluted)
$-0.00
+96.2% ▲
EBITDA
-$12K
+99.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $3K | $13K | $22K | $22K |
| Gross Profit | $0 | -$3K | -$13K | -$22K | -$22K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $333K | $0 | $120K | $0 |
| SG&A Expenses | $341K | $230K | $496K | $2M | $12K |
| Operating Expenses | $341K | $563K | $496K | $2M | $12K |
| Operating Income | -$341K | -$566K | -$509K | -$2M | -$34K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $1K | $1K | $10K | $420 | $0 |
| Income Before Tax | -$1M | -$827K | -$334K | -$2M | -$34K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$827K | -$334K | -$2M | -$34K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$1M | -$563K | -$311K | -$2M | -$12K |
| Shares Outstanding | 458M | 473M | 544M | 608M | 608M |